A London mom is calling on the city to improve safety at a pedestrian crosswalk near the Children's Museum that's surrounded by heavy traffic, construction and drivers who don't follow the ...

Goldman Sachs analyst Richard Law initiated coverage of Viking Therapeutics (VKTX) with a Neutral rating and $30 price target The company’s lead asset, VK2735, is a dual GLP-1/GIP agonist being ...

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company’s lead drug candidate is ...

Chardan analyst Geulah Livshits lowered the firm’s price target on Lexeo Therapeutics (LXEO) to $22 from $25 and keeps a Buy rating on the shares. The firm cites the company’s updated data ...

April 07, 2025 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage precision medicine company utilizing its Acrivon ...

In a report released today, Vamil Divan from Guggenheim reiterated a Buy rating on Vera Therapeutics (VERA – Research Report), with a price target of $61.00. The company’s shares closed last ...

Scotiabank analyst Louise Chen maintained a Hold rating on Sarepta Therapeutics (SRPT – Research Report) today and set a price target of $80.00. The company’s shares closed last Friday at $54.43.

Jefferies initiated coverage of Axsome Therapeutics (AXSM) with a Buy rating and $200 price target The company currently markets three central nervous system products, with two more to follow ...

Beam Therapeutics (BEAM) presented additional data from the Phase 1/2 clinical trial of BEAM-302 in patients with alpha-1 antitrypsin deficiency, AATD, at the 2025 Alpha-1 Foundation 7th Global ...

RBC Capital analyst Brian Abrahams maintained a Hold rating on Sarepta Therapeutics (SRPT – Research Report) on April 3 and set a price target of $87.00. The company’s shares closed yesterday ...

16:54 EDT Lenz Therapeutics (LENZ) files $500M mixed securities shelf Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks. Make smarter ...

16:48 EDT ZyVersa Therapeutics (ZVSA) files to sell 4.21M shares of common stock for holders Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top ...